Ownership history in CM Management, LLC · 7 quarters on record
This page tracks every 13F SEC filing in which CM Management, LLC reported a position in ROYALTY PHARMA PLC SHS (RPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 75,000 | +25,000 | +50.0% | 2.44% | $2.9M | $38.44 |
| 2025 Q3 | REDUCED | 50,000 | -110,000 | -68.8% | 1.47% | $1.8M | $34.90 |
| 2024 Q4 | UNCHANGED | 160,000 | — | 0% | 3.65% | $4.1M | $24.75 |
| 2024 Q3 | UNCHANGED | 160,000 | — | 0% | 3.61% | $4.5M | $27.23 |
As of 2025 Q4 — sorted by position size